您当前的位置:
首页 >
文章列表页 >
BET inhibitors potentiate melanoma ferroptosis and immunotherapy through AKR1C2 inhibition
LETTER TO THE EDITOR | 更新时间:2025-12-13
BET inhibitors potentiate melanoma ferroptosis and immunotherapy through AKR1C2 inhibition
BET inhibitors potentiate melanoma ferroptosis and immunotherapy through AKR1C2 inhibition
- “在xxx领域,xx专家取得了重大的研究进展。通过建立xx体系/探索xx主题/验证xx猜想,他们为解决xx问题提供了解决方案/为xx研究开辟了新方向/为xx体系的构建奠定了基础。”
- MMR 2024年11卷第4期 页码:620-624
DOI: 10.1186/s40779-023-00497-1
移动端阅览
AI导读
HTML全文
图( 1 ) 表( 0 )
参考文献
出版信息
数据统计
31
浏览量
52
下载量
0
CSCD
文章被引用时,请邮件提醒。
提交
工具集
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
相关文章
PM2.5 as a driver of human health disorders: insights from the regulated cell death pathways
Crosstalk in the brain tumor microenvironment: mechanisms, therapeutic strategies, and clinical advances
The emerging role of ferroptosis in the pathological development and progression of sepsis
Immunotherapy for tuberculosis: current strategies and future directions
ALDH2 in autophagy and cell death: molecular mechanisms and implications for diseases
相关作者
Mohammad Amin Khalilzad
Seyyed Maysam Mousavi Shoar
Amirhosein Abbasi
Mina Shafiei Falavarjani
Mitra Khalilzad
Amirhossein Naseri
Sajad Najafi
Gui-Long Tanzhu
相关机构
Department of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology
Department of Cell and Molecular Sciences, Faculty of Biological Sciences, Kharazmi University
Brain Mapping Research Center, Shahid Beheshti University of Medical Sciences
Department of Surgery, Taleghani Hospital, Shahid Beheshti University of Medical Sciences
Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences

